Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Bacterial vaginosis Stories

2009-05-23 23:33:22

Researchers at the University of Pittsburgh say they have linked a common female infection, bacterial vaginosis, to vitamin D deficiency. The study found that black women are more likely to become infected because they are more likely to be deficient in vitamin D, the Pittsburgh Post-Gazette reported Saturday. Researchers tested 469 pregnant women for vitamin D levels. They found women with low levels of the vitamin were more likely to be infected. About one-third of women in their...

2009-05-22 09:26:34

Findings may explain higher rates of infection among African-Americans Pregnant women with low levels of vitamin D may be more likely to suffer from bacterial vaginosis (BV) "“ a common vaginal infection that increases a woman's risk for preterm delivery, according to a University of Pittsburgh study. Available online and published in the June issue of the Journal of Nutrition, the study may explain why African-American women, who often lack adequate vitamin D, are three times more...

2009-05-15 08:32:47

Bacterial vaginosis (BV) is the most common vaginal infection in US women of childbearing age, and is common in pregnant women. BV occurs when the normal balance of bacteria in the vagina is disrupted and replaced by an overgrowth of certain bacteria. Because having BV puts a woman at increased risk for a variety of complications, such as preterm delivery, there is great interest in understanding how it can be prevented. Vitamin D may play a role in BV because it exerts influence over a...

2009-02-03 07:00:00

SAN ANTONIO, Feb. 3 /PRNewswire/ -- BioComp Pharma, Inc. launched Tinidazole 500, the first generic version of the FDA-approved drug Tindamax(R). Tindamax(R) is the only oral antimicrobial drug approved by the FDA for the treatment of both trichomoniasis (trich) and bacterial vaginosis (BV). BioComp Pharma will begin shipping the generic version of Tindamax(R) in February 2009. Generic drugs have the same active ingredients and efficacy as branded drugs but, on average, cost 30 to 80...

2008-10-08 09:00:51

Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, will release 2008 third quarter financial results after market close on Wednesday, October 22, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M. Radak, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. ET (2:00 p.m. PT) to discuss those results and to answer questions. To...

2008-09-16 09:00:53

Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, today announced that it will present at the UBS 2008 Global Life Sciences Conference to be held at the Grand Hyatt Hotel in New York on September 22-25, 2008. Caren Mason, President and Chief Executive Officer, will present on Monday, September 22, 2008 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). A webcast and audio archive of the presentation will be available via the...

2008-08-26 00:00:38

Previously unrecognized and unidentified infections of amniotic fluid may be a significant cause of premature birth, according to researchers at the Stanford University School of Medicine. An analysis of amniotic fluid from women in preterm labor indicated that 15 percent of the fluid samples harbored bacteria or fungi -- an increase of 50 percent over previous estimates. The heavier the burden of infection, the more likely the women were to deliver younger, sicker infants. "If we...

2008-07-09 09:01:02

Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, will release 2008 second quarter financial results after market close on Wednesday, July 23, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M. Radak, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. ET (2:00 p.m. PT) to discuss those results and to answer questions. To...

2007-07-31 09:07:53

SAN ANTONIO, July 31 /PRNewswire/ -- A study published in the August issue of Obstetrics & Gynecology, the official publication of the American College of Obstetricians and Gynecologists (ACOG), finds that Mission Pharmacal's Tindamax(R) (tinidazole) is an effective and well-tolerated treatment for bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States. BV affects almost one-third of women in the United States and is one of the...

2007-02-09 12:00:13

By Mingione, Matthew J; Pressman, Eva K; Woods, James R Abstract Our understanding of the pathophysiologic processes leading to preterm premature rupture of membranes (PPROM) has grown tremendously in recent years. Evidence suggests that there may be a genetic susceptibility to PPROM and that genetic and environmental elements are important cofactors in its development. A number of risk-based protocols have been proposed in an attempt to identify those women at highest risk for PPROM....


Latest Bacterial vaginosis Reference Libraries

72_219413818a409d6eca0e304d094c790a
2011-04-25 16:25:00

Mycoplasma genitalium is a small parasitic bacterium that lives on the ciliated epithelial cells of the primate genital and respiratory tracts. It is the smallest known free-living bacterium. Up until 2002 it was also considered to be the organism with the smallest genome. M. genitalium was isolated in 1980 from urethral specimens of two male patients with non-gonococcal urethritis. Infection is fairly common and can be transmitted between partners during unprotected sex. It can be treated...

More Articles (1 articles) »